4SCAR-GD2
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 09, 2025
Study on GD2 Positive Solid Tumors by 4SCAR-GD2
(clinicaltrials.gov)
- P1/2 | N=100 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial primary completion date: Jun 2019 ➔ Jun 2028 | Unknown status ➔ Recruiting | Trial completion date: Dec 2020 ➔ Dec 2029
Enrollment open • Trial completion date • Trial primary completion date • Solid Tumor
1 to 1
Of
1
Go to page
1